NICE recommends new ‘cost-effective’ migraine drug
National Institute for Health and Care Excellence (NICE) today recommended Teva’s migraine drug fremanezumab, sold under the brand name Ajovy, for NHS use.
The final...
This site is intended for Healthcare Professionals only.
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc
This site is intended for Healthcare Professionals only.